COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
29 Apr 2022
Historique:
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 28 4 2022
Statut: ppublish

Résumé

We examine heterogeneity in COVID-19 vaccine hesitancy across eight European countries. We reveal striking differences across countries, ranging from 6.4% of adults in Spain to 61.8% in Bulgaria reporting being hesitant. We experimentally assess the effectiveness of different messages designed to reduce COVID-19 vaccine hesitancy. Receiving messages emphasizing either the medical benefits or the hedonistic benefits of vaccination significantly increases COVID-19 vaccination willingness in Germany, whereas highlighting privileges contingent on holding a vaccination certificate increases vaccination willingness in both Germany and the United Kingdom. No message has significant positive effects in any other country. Machine learning-based heterogeneity analyses reveal that treatment effects are smaller or even negative in settings marked by high conspiracy beliefs and low health literacy. In contrast, trust in government increases treatment effects in some groups. The heterogeneity in vaccine hesitancy and responses to different messages suggests that health authorities should avoid one-size-fits-all vaccination campaigns.

Identifiants

pubmed: 35476432
doi: 10.1126/sciadv.abm9825
pmc: PMC9045608
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabm9825

Références

Lancet. 2012 Jun 9;379(9832):2151-61
pubmed: 22579125
Health Educ Behav. 2000 Oct;27(5):591-615
pubmed: 11009129
Vaccines (Basel). 2021 Apr 05;9(4):
pubmed: 33916427
J Health Econ. 2017 Mar;52:45-62
pubmed: 28183000
Eur J Intern Med. 2021 May;87:106-108
pubmed: 33810941
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33619178
Health Psychol. 2022 Feb;41(2):85-93
pubmed: 34570535
Glob Public Health. 2008;3 Suppl 1:90-103
pubmed: 19288345
Nat Hum Behav. 2021 Aug;5(8):980-989
pubmed: 34294901
Vaccines (Basel). 2021 Apr 13;9(4):
pubmed: 33924534
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941
pubmed: 29342498
Vaccines (Basel). 2021 Apr 13;9(4):
pubmed: 33924542
Proc Natl Acad Sci U S A. 2021 May 18;118(20):
pubmed: 33926993
Int J Biostat. 2016 May 1;12(1):45-63
pubmed: 27227717
Nat Hum Behav. 2020 Jul;4(7):756-768
pubmed: 32576982
Eur J Epidemiol. 2020 Apr;35(4):325-330
pubmed: 32318915
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Pediatrics. 2014 Apr;133(4):e835-42
pubmed: 24590751
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36):
pubmed: 34413212
Lancet Public Health. 2021 Jun;6(6):e416-e427
pubmed: 33991482
Cochrane Database Syst Rev. 2021 Oct 27;10:CD013265
pubmed: 34706066
J Gen Intern Med. 2021 Mar;36(3):753-761
pubmed: 33403622
Vaccines (Basel). 2021 Mar 22;9(3):
pubmed: 33810131
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Nat Hum Behav. 2018 Oct;2(10):743-749
pubmed: 31406294
N Engl J Med. 2019 Jun 6;380(23):2185-2187
pubmed: 30995368
Hum Vaccin Immunother. 2021 Sep 2;17(9):2940-2945
pubmed: 33998949
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4031-4033
pubmed: 28396427
Vaccine. 2022 Mar 8;40(11):1643-1654
pubmed: 33933316
Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7353-60
pubmed: 27382149
Annu Rev Cell Dev Biol. 2017 Oct 6;33:577-599
pubmed: 28992436
EClinicalMedicine. 2021 May 15;35:100881
pubmed: 34124631
Vaccine. 2016 Dec 20;34(52):6707-6714
pubmed: 27773475
Psychol Methods. 2009 Dec;14(4):323-48
pubmed: 19968396
Stat Med. 2018 May 10;37(10):1608-1624
pubmed: 29388228
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Lancet. 2020 Aug 22;396(10250):532-533
pubmed: 32798449
Nature. 2015 Apr 30;520(7549):609-11
pubmed: 25925459
J Epidemiol Glob Health. 2020 Mar;10(1):46-58
pubmed: 32175710
PLoS One. 2021 Apr 16;16(4):e0250123
pubmed: 33861765
Vaccines (Basel). 2021 Sep 24;9(10):
pubmed: 34696179
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):
pubmed: 34292869
Public Health. 2021 May;194:245-251
pubmed: 33965796
Lancet Public Health. 2021 Apr;6(4):e210-e221
pubmed: 33556325
Proc Natl Acad Sci U S A. 2021 Aug 10;118(32):
pubmed: 34315824
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
BMJ Open. 2021 Jun 15;11(6):e048172
pubmed: 34130963
PLoS One. 2021 Aug 11;16(8):e0255382
pubmed: 34379648
BMC Infect Dis. 2021 Apr 12;21(1):338
pubmed: 33845781

Auteurs

Janina I Steinert (JI)

Hochschule für Politik, Technical University of Munich, Munich, Germany.
TUM School of Social Sciences and Technology, Technical University of Munich, Munich, Germany.
Department of Social Policy and Intervention, University of Oxford, Oxford, UK.

Henrike Sternberg (H)

TUM School of Social Sciences and Technology, Technical University of Munich, Munich, Germany.

Hannah Prince (H)

Hochschule für Politik, Technical University of Munich, Munich, Germany.

Barbara Fasolo (B)

Department of Management, London School of Economics and Political Science, London, UK.

Matteo M Galizzi (MM)

Department of Psychological and Behavioural Science, London School of Economics and Political Science, London, UK.

Tim Büthe (T)

Hochschule für Politik, Technical University of Munich, Munich, Germany.
TUM School of Social Sciences and Technology, Technical University of Munich, Munich, Germany.
TUM School of Management, Technical University of Munich, Munich, Germany.
Duke University, Durham, NC, USA.

Giuseppe A Veltri (GA)

Department of Sociology and Social Research, University of Trento, Trento, Italy.

Classifications MeSH